Kansas City Business Journal
Cingulate raises $7.5m for controlled-release ADHD therapy
The Kansas City-based company is working on a set of therapies that utilize its 'Precision Time Release' drug-delivery platform. Cingulate's CEO, Shane Schaffer, told Drug Delivery Business News that his company set out to create an ADHD therapy that ...
Cingulate lands $7.5 million from ChemWerth founder - Kansas City ...
Cingulate Therapeutics Announces $7.5M Equity Investment from ...